CHARLOTTE, N.C.--(BUSINESS WIRE)--Monarch Medical Technologies, a medical technology company committed to safe insulin dosing, today announced that the US Food and Drug Administration (FDA) has cleared the company's newest solution, EndoTool SubQ™. “The FDA 510(k) Clearance of our newest solution comes at a critical time for hospitals and for Monarch. Today, more patients than ever require insulin during their hospitalizations. While insulin remains one of the most dangerous drugs to dose, our
| < Prev | Next > |
|---|
